Molecular Therapy

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Molecular Therapy is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,900 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1525-0016 · 1525-0024
Country
United States
Access
Not open access / not declared
Declared publication charge
3,900 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2000-01-01
  • PUBMED · 2016-09-29
Indexing
MEDLINE · PUBMED
APC
3,900 USD
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

22844

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

259

i10-index

5495

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-09-21
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
90%
ORCID iDs in current deposits
81%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
100890581
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Viral Infectious Diseases and Gene Expression in Insects
  • Viral Infectious Diseases and Gene Expression in Insects
Show all subjects (50)
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Animal Genetics and Reproduction
  • Animal Genetics and Reproduction
  • Muscle Physiology and Disorders
  • Muscle Physiology and Disorders
  • Herpesvirus Infections and Treatments
  • Herpesvirus Infections and Treatments
  • Viral gastroenteritis research and epidemiology
  • Viral gastroenteritis research and epidemiology
  • Pluripotent Stem Cells Research
  • Pluripotent Stem Cells Research
  • Mesenchymal stem cell research
  • Mesenchymal stem cell research
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Viral Infections and Immunology Research
  • Viral Infections and Immunology Research
  • Cytomegalovirus and herpesvirus research
  • Cytomegalovirus and herpesvirus research
  • Tissue Engineering and Regenerative Medicine
  • Tissue Engineering and Regenerative Medicine
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Lysosomal Storage Disorders Research
  • Lysosomal Storage Disorders Research
  • HIV Research and Treatment
  • HIV Research and Treatment
  • Biomedical Ethics and Regulation
  • Biomedical Ethics and Regulation
  • Retinal Development and Disorders
  • Retinal Development and Disorders
  • RNA regulation and disease
  • RNA modifications and cancer

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: